NO20030849L - Nytt salt av perindopril og farmasöytiske sammensetninger inneholdende det - Google Patents
Nytt salt av perindopril og farmasöytiske sammensetninger inneholdende detInfo
- Publication number
- NO20030849L NO20030849L NO20030849A NO20030849A NO20030849L NO 20030849 L NO20030849 L NO 20030849L NO 20030849 A NO20030849 A NO 20030849A NO 20030849 A NO20030849 A NO 20030849A NO 20030849 L NO20030849 L NO 20030849L
- Authority
- NO
- Norway
- Prior art keywords
- perindopril
- pharmaceutical compositions
- compositions containing
- fresh salt
- fresh
- Prior art date
Links
- IPVQLZZIHOAWMC-QXKUPLGCSA-N perindopril Chemical compound C1CCC[C@H]2C[C@@H](C(O)=O)N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@H]21 IPVQLZZIHOAWMC-QXKUPLGCSA-N 0.000 title 1
- 229960002582 perindopril Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0204847A FR2838648B1 (fr) | 2002-04-18 | 2002-04-18 | Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20030849D0 NO20030849D0 (no) | 2003-02-24 |
| NO20030849L true NO20030849L (no) | 2003-10-20 |
| NO324323B1 NO324323B1 (no) | 2007-09-24 |
Family
ID=8871521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030849A NO324323B1 (no) | 2002-04-18 | 2003-02-24 | Nytt salt av perindopril og farmasoytiske sammensetninger inneholdende det |
Country Status (37)
| Country | Link |
|---|---|
| US (1) | US6696481B2 (no) |
| EP (1) | EP1354873B1 (no) |
| JP (1) | JP3737488B2 (no) |
| KR (1) | KR100542468B1 (no) |
| CN (1) | CN1211365C (no) |
| AP (1) | AP1787A (no) |
| AR (1) | AR039428A1 (no) |
| AT (1) | ATE271036T1 (no) |
| AU (2) | AU2003222921A1 (no) |
| BR (1) | BR0300709A (no) |
| CA (1) | CA2423825C (no) |
| CR (1) | CR7576A (no) |
| DE (1) | DE60300011T2 (no) |
| DK (1) | DK1354873T3 (no) |
| EA (1) | EA005676B1 (no) |
| EC (1) | ECSP045441A (no) |
| ES (1) | ES2224092T3 (no) |
| FR (1) | FR2838648B1 (no) |
| GE (1) | GEP20074211B (no) |
| HR (1) | HRP20041079B1 (no) |
| IL (1) | IL164424A (no) |
| IS (1) | IS2842B (no) |
| MA (1) | MA27115A1 (no) |
| ME (1) | ME00454B (no) |
| MX (1) | MXPA03002346A (no) |
| NO (1) | NO324323B1 (no) |
| NZ (1) | NZ524478A (no) |
| OA (1) | OA12806A (no) |
| PL (1) | PL359321A1 (no) |
| PT (1) | PT1354873E (no) |
| RS (1) | RS51694B (no) |
| SI (1) | SI1354873T1 (no) |
| TN (1) | TNSN04206A1 (no) |
| TR (1) | TR200401793T4 (no) |
| UA (1) | UA79463C2 (no) |
| WO (1) | WO2003087050A2 (no) |
| ZA (1) | ZA200301395B (no) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2395195A (en) * | 2002-11-18 | 2004-05-19 | Cipla Ltd | Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors |
| HRP20161602T1 (hr) * | 2004-03-29 | 2016-12-30 | Les Laboratoires Servier | Postupak priprave čvrstog farmaceutskog pripravka |
| SI21800A (sl) | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
| DK1679072T5 (da) * | 2005-01-06 | 2009-04-20 | Ipca Lab Ltd | Fremgangsmåde til syntese af (2S,3aS,7aS)-1-(S)-alanyl-octahydro-1H-indol-2-carboxylsyrederivater og anvendelse i syntesen af perindopril |
| HRP20090548T1 (hr) * | 2005-03-14 | 2009-11-30 | Les Laboratoires Servier | Poboljšani postupak za pročišćavanje perindoprila |
| FR2894825B1 (fr) * | 2005-12-21 | 2010-12-03 | Servier Lab | Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent |
| FR2897865B1 (fr) * | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| FR2897866B1 (fr) | 2006-02-28 | 2008-04-18 | Servier Lab | Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| SI22542A (sl) * | 2007-06-04 | 2008-12-31 | Diagen D.O.O. | Stabilna formulacija amorfnih soli perindoprila, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije |
| AU2009263737B2 (en) | 2008-06-24 | 2013-10-24 | Tianish Laboratories Private Limited | Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof |
| AU2009212902A1 (en) * | 2008-09-03 | 2010-03-18 | Apotex Pharmachem Inc. | Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof |
| CN101766598A (zh) * | 2008-12-31 | 2010-07-07 | 东英(江苏)药业有限公司 | 含有培哚普利的药物组合物 |
| GB0910692D0 (en) * | 2009-06-20 | 2009-08-05 | Teva Pharma | Compound |
| SI23149A (sl) | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
| FR2961105B1 (fr) * | 2010-06-15 | 2013-02-08 | Servier Lab | Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque |
| FR2985512B1 (fr) | 2012-01-05 | 2014-06-20 | Servier Lab | Procede de preparation du sel de l-arginine du perindopril |
| FR2985511B1 (fr) * | 2012-01-05 | 2014-01-03 | Servier Lab | Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| CN103172696B (zh) * | 2012-12-19 | 2014-12-17 | 宁波美诺华药业股份有限公司 | 一种γ晶型的培哚普利精氨酸盐的制备方法 |
| FR3040303B1 (fr) * | 2015-08-27 | 2019-04-05 | Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger | Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca |
| PH12018502155B1 (en) | 2016-04-20 | 2024-03-27 | Servier Lab | Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid |
| EP3842035A1 (en) | 2019-12-23 | 2021-06-30 | KRKA, d.d., Novo mesto | Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules |
| SI26268A (sl) | 2021-11-18 | 2023-05-31 | Zupet Rok | Postopek za pripravo hidratirane oblike perindopril l-arginina |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2503155A2 (fr) * | 1980-10-02 | 1982-10-08 | Science Union & Cie | Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme |
| FR2811320B1 (fr) * | 2000-07-06 | 2002-08-23 | Adir | Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent |
-
2002
- 2002-04-18 FR FR0204847A patent/FR2838648B1/fr not_active Expired - Lifetime
-
2003
- 2003-02-17 UA UA20041109440A patent/UA79463C2/uk unknown
- 2003-02-17 AT AT03290383T patent/ATE271036T1/de active
- 2003-02-17 EP EP03290383A patent/EP1354873B1/fr not_active Expired - Lifetime
- 2003-02-17 RS YU90904A patent/RS51694B/sr unknown
- 2003-02-17 PT PT03290383T patent/PT1354873E/pt unknown
- 2003-02-17 DK DK03290383T patent/DK1354873T3/da active
- 2003-02-17 WO PCT/FR2003/000507 patent/WO2003087050A2/fr not_active Ceased
- 2003-02-17 TR TR2004/01793T patent/TR200401793T4/xx unknown
- 2003-02-17 AU AU2003222921A patent/AU2003222921A1/en not_active Abandoned
- 2003-02-17 GE GEAP8501A patent/GEP20074211B/en unknown
- 2003-02-17 ME MEP-2008-688A patent/ME00454B/me unknown
- 2003-02-17 SI SI200330002T patent/SI1354873T1/xx unknown
- 2003-02-17 ES ES03290383T patent/ES2224092T3/es not_active Expired - Lifetime
- 2003-02-17 OA OA1200400279A patent/OA12806A/en unknown
- 2003-02-17 DE DE60300011T patent/DE60300011T2/de not_active Expired - Lifetime
- 2003-02-17 AP APAP/P/2004/003154A patent/AP1787A/en active
- 2003-02-17 HR HRP20041079AA patent/HRP20041079B1/hr not_active IP Right Cessation
- 2003-02-20 ZA ZA200301395A patent/ZA200301395B/xx unknown
- 2003-02-21 US US10/371,865 patent/US6696481B2/en not_active Expired - Lifetime
- 2003-02-24 NO NO20030849A patent/NO324323B1/no not_active IP Right Cessation
- 2003-02-27 AU AU2003200700A patent/AU2003200700C1/en not_active Revoked
- 2003-02-28 NZ NZ524478A patent/NZ524478A/en not_active IP Right Cessation
- 2003-03-07 CN CNB031071481A patent/CN1211365C/zh not_active Expired - Lifetime
- 2003-03-18 MX MXPA03002346A patent/MXPA03002346A/es active IP Right Grant
- 2003-03-20 KR KR1020030017434A patent/KR100542468B1/ko not_active Expired - Lifetime
- 2003-03-21 BR BR0300709-0A patent/BR0300709A/pt not_active Application Discontinuation
- 2003-03-24 PL PL03359321A patent/PL359321A1/xx not_active Application Discontinuation
- 2003-03-25 JP JP2003083250A patent/JP3737488B2/ja not_active Expired - Lifetime
- 2003-04-03 EA EA200300334A patent/EA005676B1/ru unknown
- 2003-04-03 CA CA002423825A patent/CA2423825C/fr not_active Expired - Fee Related
- 2003-04-16 AR ARP030101332A patent/AR039428A1/es not_active Application Discontinuation
-
2004
- 2004-10-05 IL IL164424A patent/IL164424A/en active IP Right Grant
- 2004-10-15 TN TNP2004000206A patent/TNSN04206A1/en unknown
- 2004-10-27 IS IS7516A patent/IS2842B/is unknown
- 2004-11-03 MA MA27926A patent/MA27115A1/fr unknown
- 2004-11-18 EC EC2004005441A patent/ECSP045441A/es unknown
- 2004-11-18 CR CR7576A patent/CR7576A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030849D0 (no) | Nytt salt av perindopril og farmasöytiske sammensetninger inneholdende det | |
| IS7543A (is) | Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær | |
| IS2504B (is) | Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra | |
| IS7552A (is) | Bensótengdar heteróarýl amíð afleiður af þíenópýridíni, gagnlegar sem meðferðarmiðlar, lyfjasamsetningar sem innihalda þær og aðferðir við notkun þeirra | |
| IL163931A (en) | Derivatives of Tetrazycline Compounds Converted by Amino Methyl and Pharmaceutical Preparation Containing Them | |
| NO20033538L (no) | Nytt suksinatsalt av O-desmetyl-venlafaxine | |
| CY2015003I2 (el) | Φαρμακευτικες συνθεσεις για θεραπεια καρκινου | |
| IS7735A (is) | Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær. | |
| NO20053890D0 (no) | Syntese av 4amino-2-butenolklorider og anvendelse derav for fremstilling av 3-cyanokinoliner | |
| IS7714A (is) | Lyfjasamsetningar úr módafíníl | |
| NO20043902L (no) | Kontrollert syntese av ziprasidon og sammensetninger derav | |
| IS7859A (is) | Indasól efnasambönd og lyfjasamsetningar til að hindra prótín kínasa og aðferðir við notkun þeirra | |
| NO20055417D0 (no) | Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor | |
| CY2018005I2 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
| DK1635791T3 (da) | Farmaceutisk komposition omfattende atorvastatin og fremstillet uden granulering | |
| EP1620553A4 (en) | INSECT CHYMOTRYPSIN AND INHIBITORS THEREOF | |
| PL361518A1 (pl) | Zastosowanie substancji oraz kompozycja farmaceutyczna | |
| EP1585519A4 (en) | HIGH CONCENTRATION OPIOID FORMULATIONS AND OPIOID DERIVATIVES | |
| NO20053874L (no) | Formulering og metoder for behandling av thrombocytemi | |
| IL163959A (en) | Derivatives of phenyl-sulfonylamino- benzoic acid and pharmaceutical compositions comprising them | |
| IS7424A (is) | Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær | |
| FR2834893B1 (fr) | Composition pharmaceutique orodispersible de perindopril | |
| IL169312A0 (en) | Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it | |
| IS6234A (is) | Ný lyfjaform og aðferðir við tilreiðslu þeirra | |
| DK1413579T3 (da) | Imidazolinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |